PMC:7408073 / 93114-93515
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T501 | 136-142 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T502 | 329-335 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3233 | 162-167 | Gene | denotes | rACE2 | Gene:302668 |
| 3234 | 322-325 | Gene | denotes | ACE | Gene:59272 |
| 3235 | 379-383 | Gene | denotes | ACE2 | Gene:59272 |
| 3263 | 227-235 | Gene | denotes | Ang (1–9 | Gene:284 |
| 3285 | 156-161 | Species | denotes | human | Tax:9606 |
| 3286 | 190-198 | Species | denotes | patients | Tax:9606 |
| 3287 | 392-400 | Species | denotes | patients | Tax:9606 |
| 3319 | 185-189 | Disease | denotes | ARDS | MESH:D012128 |
| 3320 | 387-391 | Disease | denotes | ARDS | MESH:D012128 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T530 | 185-189 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
| T531 | 387-391 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1131 | 136-142 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T1132 | 156-161 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T1133 | 261-263 | http://purl.obolibrary.org/obo/CLO_0008426 | denotes | pg |
| T1134 | 310-318 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T1135 | 329-335 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T451 | 0-401 | Sentence | denotes | In normal healthy subjects, it was reproducibly below the limit of quantification [179,180], differently, both in ex vivo treatments of plasma samples with human rACE2 [115,181] and in ARDS patients, it was markedly increased (Ang (1–9) ranged between 100–3080 pg/mL) [92], suggesting both that the dominating activity of ACE in plasma of healthy subjects is overcome by that of ACE2 in ARDS patients. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32708755-25107336-20679002 | 83-86 | 25107336 | denotes | 179 |
| 32708755-2170511-20679003 | 87-90 | 2170511 | denotes | 180 |
| 32708755-22777933-20679004 | 169-172 | 22777933 | denotes | 115 |
| 32708755-22518284-20679005 | 173-176 | 22518284 | denotes | 181 |
| 32708755-30845246-20679006 | 269-271 | 30845246 | denotes | 92 |